Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial Bagot, M., Kim, Y. H., Ortiz-Romero, P. L., Zinzani, P., Mehta-Shah, N., Dereure, O., Beylot-Barry, M., Dalle, S., Jacobsen, E. D., Huen, A., Combalia, A., Battistella, M., Gru, A. A., Moins-Teisserenc, H., Khodadoust, M. S., Viotti, J., Paiva, C., Muller, M., Porcu, P. AMER SOC HEMATOLOGY. 2022: 3760-3761

View details for DOI 10.1182/blood-2022-160239

View details for Web of Science ID 000893223203349